You are here

Galapagos

The 5 largest biopharma layoffs of Q1 2025

BioSpace

Fri, 04/11/25 - 11:47 am

Bristol Myers Squibb

Gilead Sciences

What’s driving pharma’s layoffs in 2025

Pharma Voice

Mon, 03/10/25 - 09:27 am

CRISPR Therapeutics

Atara Biotherapeutics

Bristol Myers Squibb

Galapagos drops one CD19 CAR-T to focus on 'flagship' program

Fierce Biotech

Thu, 02/13/25 - 09:48 pm

Galapagos unveils plan to split, hiving off its drugs unit

Pharmaphorum

Wed, 01/8/25 - 11:13 am

Galapagos Surges On An FDA Win For Its Rival To Gilead, Novartis; But There Are Some Caveats

Investors Business Daily

Mon, 08/26/24 - 11:11 am

non-Hodgkin lymphoma

Gilead Sciences

FDA grants IND clearance for Galapagos’ non-Hodgkin lymphoma therapy trial

Clinical Trials Arena

Fri, 08/23/24 - 10:49 am

non-Hodgkin lymphoma

clinical trials

Galapagos pauses CAR-T cell therapy trial over Parkinsonism case

Fierce Biotech

Fri, 08/2/24 - 11:36 am

clinical trials

Galapagos selects Adaptimmune T-cell therapy for $665M biobucks collab

Fierce Biotech

Fri, 05/31/24 - 10:52 am

t-cell therapies

Galapagos Partners with Blood Centers of America to Decentralize CAR-T Production

BioSpace

Thu, 05/16/24 - 11:28 am

Blood Centers of America

clinical trials

Galapagos halts lupus CAR-T program, confirms 100 layoffs so far this year

Fierce Biotech

Fri, 02/23/24 - 10:32 am

Frontier gets $80M, Galapagos’ backing to make a better KRAS drug

BioPharma Dive

Thu, 02/22/24 - 11:18 pm

Frontier Medicines

KRAS inhibitors

Galapagos wants to find new small molecule species for cancer with BridGene

Fierce Biotech

Wed, 01/3/24 - 05:05 pm

BridGene Biosciences

small molecule drugs

Alfasigma to acquire Galapagos’ Jyseleca business

Pharmaceutical Business Review

Tue, 01/2/24 - 09:58 am

ulcerative colitis

rheumatoid arthritis

Galapagos plans to cut 100 jobs after striking deal to transfer Jyseleca, 400 staffers to Alfasigma

Fierce Pharma

Tue, 10/31/23 - 11:28 am

Galapagos, following Sanofi’s playbook, offloads French R&D site to drug discovery CRO

Fierce Biotech

Fri, 03/31/23 - 10:27 am

Galapagos' Jyseleca flops phase 3 Crohn's study, dealing another blow to troubled JAK inhibitor

Fierce Pharma

Fri, 02/10/23 - 11:09 am

Crohn's Disease

clinical trials

Galapagos lays off 200 staff, drops kidney and fibrosis programs in renewed CAR-T push

Fierce Biotech

Fri, 11/4/22 - 11:01 am

Plaque psoriasis and psoriatic arthritis: trials to watch in 2022

Clinical Trials Arena

Tue, 08/9/22 - 06:32 am

clinical trials

psoriatic arthritis

Galapagos cleans closet of another 4 programs to make room for CAR-T ambitions

Fierce Biotech

Sun, 08/7/22 - 11:22 pm

In first M&A strike, Paul Stoffels lays out 5-year plan to turn Galapagos around

Fierce Biotech

Thu, 06/23/22 - 10:54 am

Pages